Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Infection|November 24, 1998
An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative GroupD W Denning, A Marinus, J Cohen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 28, 2000
The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial. EORTC Radiotherapy and Breast Cancer Cooperative GroupsC Vrieling, L Collette, A Fourquet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 1998
Intensive induction-sequential chemotherapy with BOP/VIP-B compared with treatment with BEP/EP for poor-prognosis metastatic nonseminomatous germ cell tumor: a Randomized Medical Research Council/European Organization for Research and Treatment of Cancer studyS B Kaye, G M Mead, S Fossa, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2009
Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991O Matzinger, F Duclos, A van den Bergh, et al.
British Journal of Cancer|November 21, 1998
Serum alpha-fetoprotein surge after the initiation of chemotherapy for non-seminomatous testicular cancer has an adverse prognostic significanceR de Wit, L Collette, R Sylvester, et al.
European Urology|January 1, 2003
Tissue polypeptide-specific antigen (TPS) determinations before and during intermittent maximal androgen blockade in patients with metastatic prostatic carcinomaP J M Kil, H M J Goldschmidt, B J A Wieggers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 30, 1998
An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosisM Ellis, D Spence, B de Pauw, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 2009
Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014)O Matzinger, F Roelofsen, L Mineur, et al.
Lancet (London, England)|September 20, 2005
Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trialM J van den Bent, D Afra, O de Witte, et al.
International Journal of Radiation Oncology, Biology, Physics|October 19, 1999
The influence of the boost in breast-conserving therapy on cosmetic outcome in the EORTC "boost versus no boost" trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups. European Organization for Research and Treatment of CancerC Vrieling, L Collette, A Fourquet, et al.
Pageof 10